Industry Veteran Paul Brennan Appointed Effective Nov 1st VICTORIA, BC –– Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery… Read More
VANCOUVER, BC — /PRNewswire/ — With the foreseeable increase in outdoor travelling in the near future, as well as the ever-expanding prospects of self-driving vehicles that have been reported to… Read More
MISSISSAUGA, ON — Gilead Sciences Canada, Inc. (Gilead Canada) announced today that Christophe Griolet joined the organization as Vice President and General Manager. In his new role, Griolet will be responsible… Read More
European Medicines Agency (EMA) validates AbbVie’s Marketing Authorization Application; Genmab submits Biologics License Application to U.S. Food and Drug Administration (FDA) The submissions are supported by the EPCORE™ NHL-1 open-label, multi-center… Read More
Winners receive the ultimate recognition for innovation that improves the human condition NEW YORK /PRNewswire/ — The Prix Galien USA Committee honored excellence and innovation in life sciences during the Prix Galien USA Forum and 16th annual… Read More
